Abstract
This report covers the total FP2020 public sector market – defined as volumes purchased by institutional buyers (USAID, UNFPA, SMOs, etc.) and Ministry of Health (MOH) or government-affiliated procurers for the 69 FP2020 focus countries. The report highlights trends between 2011 and 2015, with a focus on significant new findings for the period from 2013 to 2015. Where percentage changes are discussed, the Compound Annual Growth Rate (CAGR) is used unless otherwise noted. Numbers may vary slightly between exhibits due to rounding.
There was a significant increase in demand for implants between 2011 and 2015. The sizeable increase in demand for implants from six million units to 10 million units from 2013 to 2015 has resulted in long-acting and reversible contraceptives (LARCs) now making up 34 percent of the total FP2020 public sector market value. The spend on implants and IUDs has grown to US$92 million in 2015, up from US$55 million in 2013. LARCs now also represent over 50 percent of the overall implied method mix (Exhibits 1-3, 5). Short-acting methods (including condoms, injectables, and oral contraceptives) represent 66 percent of the total FP2020 public sector market value in 2015, down from 80 percent in 2013.
